CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-02 | McMullin David Chief Commercial Officer | Grant or award | +247,480 | 255,183 | ||
| 2020-03-02 | McMullin David Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2020-03-02 | Reed Joshua Chief Financial Officer | Grant or award | +250,000 | 285,774 | ||
| 2020-03-02 | Reed Joshua Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +137,707 | 137,707 | ||
| 2020-03-02 | McMullin David Chief Commercial Officer | Grant or award | +250,000 | 257,703 | ||
| 2020-03-02 | McMullin David Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +247,480 | 247,480 | ||
| 2020-03-02 | Brady Todd C President and CEO | Grant or award | +250,000 | 902,216 | ||
| 2020-03-02 | Brady Todd C President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2020-03-02 | Brady Todd C President and CEO | Grant or award · Bonus Units | +450,865 | 450,865 | ||
| 2020-01-13 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +24,264 | 24,264 | ||
| 2019-12-16 | Brady Todd C President and CEO | Purchase | +20,000 | $5.10 | $102K | 652,216 |
| 2019-09-30 | Brady Todd C President and CEO | Purchase | +8,710 | $5.68 | $49K | 632,216 |
| 2019-09-23 | Brady Todd C President and CEO | Purchase | +8,680 | $5.81 | $50K | 623,506 |
| 2019-09-18 | Brady Todd C President and CEO | Purchase | +14,288 | $5.91 | $84K | 614,826 |
| 2019-09-17 | Bronstein Ben Director | Purchase | +1,700 | $5.85 | $10K | 18,644 |
| 2019-09-16 | Brady Todd C President and CEO | Purchase | +3,000 | $6.03 | $18K | 600,538 |
| 2019-09-16 | Brady Todd C President and CEO | Purchase | +3,000 | $6.03 | $18K | 591,991 |
| 2019-09-13 | Brady Todd C President and CEO | Purchase | +18,547 | $5.90 | $109K | 597,538 |
| 2019-09-13 | DOUGLAS RICHARD Director | Purchase | +5,000 | $6.00 | $30K | 85,000 |
| 2019-09-13 | Brady Todd C President and CEO | Purchase | +10,000 | $5.79 | $58K | 588,991 |
Page 11 of 19 · 376 trades